FRUQUINTINIB VERSUS PLACEBO IN PATIENTS WITH REFRACTORY METASTATIC COLORECTAL CANCER (FRESCO-2): AN INTERNATIONAL, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PHASE 3 STUDY. Maggio 17, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS IN HOME, Uncategorized/da Luisa
ELACESTRANT (ORAL SELECTIVE ESTROGEN RECEPTOR DEGRADER) VERSUS STANDARD ENDOCRINE THERAPY FOR ESTROGEN RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE ADVANCED BREAST CANCER: RESULTS FROM THE RANDOMIZED PHASE III EMERALD TRIAL. Maggio 13, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS IN HOME/da Luisa
VENERDI 10-SABATO 11 MAGGIO 2024 NEGRAR DI VALPOLICELLA (VR) SCUOLA DI METODOLOGIA CLINICA Maggio 2, 2024/0 Commenti/in EVENTI, NEWS, NEWS IN HOME/da Luisa
GIOVEDI 9 MAGGIO 2024 NEGRAR DI VALPOLICELLA (VR) SCUOLA DI METODOLOGIA DELLA RICERCA CLINICA Maggio 2, 2024/0 Commenti/in EVENTI, NEWS, NEWS IN HOME/da Luisa
RIPRETINIB IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMOURS (INVICTUS): A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PHASE 3 TRIAL Maggio 2, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS IN HOME/da Luisa
AIGOM-LE NOVITA’ DA CHICAGO 2024: L’EVOLUZIONE DELLE CONOSCENZE IN ONCOLOGIA… Aprile 26, 2024/0 Commenti/in EVENTI, NEWS, NEWS IN HOME/da Luisa
OSSERVATORIO CIVILE E CITTADINANZA ATTIVA- NGS E MTB: LO STATO DELL’ARTE REGIONALE-INSTANT BOOK Aprile 22, 2024/0 Commenti/in NEWS, NEWS IN HOME/da Luisa
EVENT-FREE SURVIVAL BY RESIDUAL CANCER BURDEN WITH PEMBROLIZUMAB IN EARLY-STAGE TRIPLE NEGATIVE BREAST CANCER (TNBC): EXPLORATORY ANALYSIS FROM KEYNOTE-522 Aprile 18, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS IN HOME/da Luisa
DOSTARLIMAB FOR PRIMARY ADVANCED OR RECURRENT ENDOMETRIAL CANCER. Aprile 15, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS IN HOME/da Luisa
